ENDV (Endonovo Therapeutics) Payments of Debt: $-0.15 Mil (TTM As of Jun. 2025)


What is Endonovo Therapeutics Payments of Debt?

Endonovo Therapeutics ENDV -99.00% Payments of Debt is $-0.15 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Endonovo Therapeutics's Payments of Debt for the three months ended in Jun. 2025 was $0.00 Mil.

Endonovo Therapeutics's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.15 Mil.

Endonovo Therapeutics Payments of Debt Related Terms

Endonovo Therapeutics Payments of Debt Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Payments of Debt Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.47 -0.12 -0.20

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.00 -0.15 0.00 0.00

Endonovo Therapeutics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-0.15 Mil mean?
Endonovo Therapeutics (ENDV) has a Payments of Debt of $-0.15 Mil as of Jun. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Endonovo Therapeutics and its competitors.
Is Endonovo Therapeutics' Payments of Debt too high?
Endonovo Therapeutics' current Payments of Debt is $-0.15 Mil.
How does Endonovo Therapeutics' Payments of Debt compare to RGBP and SIGY?
Endonovo Therapeutics' Payments of Debt of $-0.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current Payments of Debt is $-0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current Payments of Debt of $-0.15 Mil. The current Payments of Debt is $-0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Payments of Debt is $-0.15 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.